| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/21/2005 | US20050158833 Using enhanced green fluorescent protein as reporter molecule in studying cell lineages |
| 07/21/2005 | US20050158832 Secreted glycoprotein hormone fusion for use in regulating the level of red blood cells in circulation |
| 07/21/2005 | US20050158831 Using tumor necrosis factor superfamily polypeptides (TNFSF) as therapeutic agents in treatment of cell proliferative, inflammatory, autoimmune, cardiovascular and viral infection; tumor immunotherapy; wound healing agents |
| 07/21/2005 | US20050158830 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/21/2005 | US20050158829 Fusion polypeptides capable of activating receptors |
| 07/21/2005 | US20050158827 Using nervous system membrane protein receptors for use as screening tools in identifying modulators of nervous system dysfunction |
| 07/21/2005 | US20050158826 Using tumor necrosis factor receptor releasing enzyme as therapeutic tool in treatment of inflammation, arthritis, rheumatoid arthritis and multiple sclerosis |
| 07/21/2005 | US20050158824 Using chinese hamster ovaries as bioreactor for production of nerve growth factor for use in prevention and treatment of nervous system disorders |
| 07/21/2005 | US20050158823 Using tumor necrosis factor related apoptosis inducing ligand (TRAIL) as tool in tissue targeted treatment of cancer cells |
| 07/21/2005 | US20050158822 Expresion vector comprising nucleotide sequences coding secreted glycoprotein hormone with modified untranslated region for use in enhancement of blood production; directed protein evolution |
| 07/21/2005 | US20050158821 Methods for the purification and aqueous fiber spinning of spider silks and other structural proteins |
| 07/21/2005 | US20050158816 Using yeast model comprising aequorin reporter as tool in screening compound toxicity; bioassay and drug screening |
| 07/21/2005 | US20050158810 Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3 |
| 07/21/2005 | US20050158804 N-terminal cysteine cleaves thioester bond; amidation; ubiquitin fusion proteins; proteolysis |
| 07/21/2005 | US20050158800 Detecting the expression of a G-protein coupled receptor, identifying agonists or antagonists of the receptor |
| 07/21/2005 | US20050158799 TRIF-related adaptor molecule (TRAM) and uses thereof |
| 07/21/2005 | US20050158796 Use of a tag to enrich polypeptides libraries |
| 07/21/2005 | US20050158794 Luminescent markers |
| 07/21/2005 | US20050158793 Immunoassays |
| 07/21/2005 | US20050158792 Nucleotide sequences coding prostate cancer antigen (PCA3DD3) for diagnosing and treating cancer; antitumor agents |
| 07/21/2005 | US20050158786 Expression vector comprising nucleotide sequences coding membrane receptor for use in identifying modulator for prevention and treatment of metabolic disorders; hormone replacement therapy |
| 07/21/2005 | US20050158784 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof |
| 07/21/2005 | US20050158780 Nucleic acid ligands to the prostate specific membrane antigen |
| 07/21/2005 | US20050158779 Tumor antigen probes for detection of cell proliferative disorders |
| 07/21/2005 | US20050158778 Transcription factor for use in generating immoglobulin for prevention and treatment of fungal infection |
| 07/21/2005 | US20050158775 Transgenic animal cell comprising expression vector coding transmembrane/fatty acid synthase fusion for use as model in prevention and treatment of cancer or/an autoimmune disease |
| 07/21/2005 | US20050158771 Using gene expression patterns and skeletal muscle marker as diagnostic tool in detection and prognostication of obesity |
| 07/21/2005 | US20050158764 Alternatively spliced juvenile hormone receptor genes for use in identifying modulators for insect propagation; biological pest control |
| 07/21/2005 | US20050158760 Interleukin-10 homolog for use as a therapeutic tool in treatment and prevention of inflammatory, autoimmue and cell proliferative disorders |
| 07/21/2005 | US20050158754 Nucleotide sequences coding testis specific-protein y-like (TSPYL) genes for use in identifying modulator for treatment and prevention of sudden infant death with dysgenesis of the testes syndrome (SIDDT) |
| 07/21/2005 | US20050158753 Using presence of gastrointestinal system protein (CS141) as diagnostic indcator of gastrointestinal disorders; diagnosing colon and rectum cancer |
| 07/21/2005 | US20050158750 Expression vector comprising nucleotide sequences coding interleukin specific immunoglobulin for use in regulating activation, development, differentiation and function of hematopoietic cells |
| 07/21/2005 | US20050158747 Gene therapy; microarrays |
| 07/21/2005 | US20050158740 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof |
| 07/21/2005 | US20050158737 Tumour associated antigens |
| 07/21/2005 | US20050158727 Derivatized oligonucleotides having improved uptake and other properties |
| 07/21/2005 | US20050158724 Methods, of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 07/21/2005 | US20050158719 Polypeptide serving as angiogenic marker and dna thereof |
| 07/21/2005 | US20050158716 Nucleic acid detection kits |
| 07/21/2005 | US20050158714 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 07/21/2005 | US20050158712 Methods for purifying viral particles for gene therapy |
| 07/21/2005 | US20050158711 viral vector containing a polynucleotide sequence contains two different affinity tag sequences, one of the two affinity tag sequences encodes streptavidin-binding peptide and other encodes calmodulin binding peptide |
| 07/21/2005 | US20050158708 High thoughput assay; rapid profiling; proteomics |
| 07/21/2005 | US20050158705 Gene screening method using nuclear receptor |
| 07/21/2005 | US20050158345 ABC (ATP-binding cassette) transporters; polynucleotides, expression vectors, transformed host cells and antibodies; use in vaccination |
| 07/21/2005 | US20050158344 Exoenzyme toxin of aeromonas salmonicida, and uses thereof |
| 07/21/2005 | US20050158343 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 07/21/2005 | US20050158341 Tat and Nef to promote localized accumulation of CD4+ cells, and a compound that stimulates the differentiation of CD4+ ThO cells into either Th1 cells or Th2 cells such as interleukin-4 or an antibody that is capable of binding interferon gamma; treating HIV infections |
| 07/21/2005 | US20050158340 Recombinant RSV virus expression systems and vaccines |
| 07/21/2005 | US20050158338 Both human and bovine polynucleotide sequences, as well as a major nucleocapsid (N) protein, a nucleocapsid phosphoprotein (P), a large polymerase protein (L), and a RNA polymerase elongation factor combined with heterologous gene(s); vaccines |
| 07/21/2005 | US20050158336 Antigenic peptides, e.g. fusion peptides of CTL epitope peptides and a T helper peptide, conjugated to an immunostimulatory DNA oligomer; cytosine-phosphate-guanosine (CpG); enhanced recognition of the substance by the immune system e.g. HIV vaccines, cancer vaccines |
| 07/21/2005 | US20050158335 Polynucleotides from a gene cluster encoding pilin polypeptides; treating or immunizing against infections such as otitis media; antibodies, assays |
| 07/21/2005 | US20050158333 Methods and products related to metabolic interactions in disease |
| 07/21/2005 | US20050158332 MHC-Class II restricted melanoma antigens and their use in therapeutic methods |
| 07/21/2005 | US20050158322 Single chain Fv antibody fragments; for diagnosis/prognosis of human colorectal tumors |
| 07/21/2005 | US20050158317 Novel proteins with il-6 inhibiting activity |
| 07/21/2005 | US20050158315 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 07/21/2005 | US20050158312 Related to the carboxylate transporter subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity |
| 07/21/2005 | US20050158308 For treating, preventing, or ameliorating bone-related or cartilage-related diseases such as osteoporosis; transgenic, knock-out mammals; immunization |
| 07/21/2005 | US20050158302 Methods for diagnosing and treating autoimmune disease |
| 07/21/2005 | US20050158295 Modified plasminogen inhibitor type-1 and methods based thereon |
| 07/21/2005 | US20050158287 Methods for using the obese gene and its gene product to identify hematopoietic progenitor cells |
| 07/21/2005 | US20050158282 epidermal growth factor (EGF) producing Lactococcus lactis and Lactobacillus casei ( lactic acid bacterium); useful to treat Short Bowel Syndrome; increase intestinal villi height |
| 07/21/2005 | US20050158279 Administering a negative-strand RNA viral vector (sendai virus) containing FGF-1 or FGF-5 (fibroblast growth factors) as a foreign gene to animals; gene therapy |
| 07/21/2005 | DE10359352A1 DNA-Sequenz und rekombinante Herstellung des Graspollen-Allergens Lol p 4 DNA sequence and recombinant production of the grass pollen allergen Lol p 4 |
| 07/21/2005 | DE10359351A1 DNA-Sequenz und rekombinante Herstellung von Gruppe-4 Majorallergenen aus Getreiden DNA sequence and recombinant production of group 4 major allergens from cereals |
| 07/21/2005 | CA2592891A1 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
| 07/21/2005 | CA2552590A1 Interleukin-12 targeted to oncofoetal fibronectin |
| 07/21/2005 | CA2552526A1 Glucagon-like peptide-1 analogs with long duration of action |
| 07/21/2005 | CA2552251A1 Targeted immunogens |
| 07/21/2005 | CA2552222A1 Antiviral compositions which inhibit paramyxovirus infection |
| 07/21/2005 | CA2552188A1 Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof |
| 07/21/2005 | CA2551905A1 Nucleic acid encoding a novel prostaglandin receptor protein and methods of use thereof |
| 07/21/2005 | CA2551877A1 Neutralizing epitope-based growth enhancing vaccine |
| 07/21/2005 | CA2551484A1 Methods for eliminating mannosylphosphorylation of glycans in the production of glycoproteins |
| 07/21/2005 | CA2551131A1 Novel recombinant proteins with n-terminal free thiol |
| 07/21/2005 | CA2550854A1 Membranes incorporating recognition moieties |
| 07/21/2005 | CA2550642A1 Oligonucleotide compound and method for treating nidovirus infections |
| 07/21/2005 | CA2550245A1 Fibroblast growth factor receptors 1, 2, 3, and 4 as targets for therapeutic intervention |
| 07/21/2005 | CA2548990A1 Toll-like receptor 4 (tlr4)-neutralizing antibodies |
| 07/21/2005 | CA2548896A1 Multimeric galectin-1 and its use for inducing il-10 production |
| 07/20/2005 | EP1555328A2 Recombinant library screening methods |
| 07/20/2005 | EP1555325A1 Novel fructosyl peptide oxidase and utilization thereof |
| 07/20/2005 | EP1555324A1 Defructosylation method |
| 07/20/2005 | EP1555323A2 Ph sensitive mutants of GFP for optically detecting changes in cellular microenvironments |
| 07/20/2005 | EP1555322A1 Lipolytic enzyme variant |
| 07/20/2005 | EP1555320A2 Expression system derived from the lipase regulation cascade of Pseudomonas alcaligenes |
| 07/20/2005 | EP1555319A2 Modified nucleic acid sequences and method to increasing mRNA levels and protein expression in cell systems |
| 07/20/2005 | EP1555318A2 Hematopoietic cytokine receptor |
| 07/20/2005 | EP1555316A2 Antigen library immunization |
| 07/20/2005 | EP1555314A2 Enzymes and detergent compositions |
| 07/20/2005 | EP1555271A1 Peptides useful for diagnosis and therapy of TRP-2+ and/or TRP-1+ tumors |
| 07/20/2005 | EP1555270A1 HCV NS3 proteins and nucleic acids |
| 07/20/2005 | EP1554572A2 Compositions and methods for modulating blood-brain barrier transport |
| 07/20/2005 | EP1554405A1 Compositions, methods, and kits relating to behab and primary cns tumors |
| 07/20/2005 | EP1554403A1 Autism gene |
| 07/20/2005 | EP1554397A2 Type 2 diabetes susceptibility genes |
| 07/20/2005 | EP1554393A2 P27 prevents cellular migration |
| 07/20/2005 | EP1554384A1 E.coli host cells with modified phos/psts periplasmic phosphate-binding proteins , and method of manufacturing recombinant fabs |
| 07/20/2005 | EP1554382A1 Gpr54 knock-out mammals and screening methods using them |